Data is not available at this time.
Zhejiang NHU Company Ltd. operates as a diversified specialty chemicals manufacturer with a strategic focus on high-value segments including nutritional products, flavors and fragrances, advanced polymers, and active pharmaceutical ingredients. The company has established a vertically integrated production model that spans from basic chemical synthesis to sophisticated fine chemicals, serving diverse end markets across feed additives, food and beverage, personal care, electronics, and pharmaceuticals. NHU's core revenue model is built on manufacturing and selling these specialized chemical products, leveraging its technological expertise and production scale to maintain competitive positioning. Within China's chemical industry landscape, NHU has carved out a distinctive niche by focusing on products requiring complex synthesis capabilities and stringent quality standards, positioning itself as a key supplier to both domestic and international markets. The company's diversified portfolio provides natural hedging against cyclical downturns in specific sectors while allowing it to capitalize on growth trends in nutrition, healthcare, and advanced materials. NHU's market position is strengthened by its continuous R&D investments and ability to develop proprietary manufacturing processes for high-margin specialty chemicals.
NHU demonstrated robust financial performance with revenue of CNY 21.6 billion and net income of CNY 5.87 billion, translating to a healthy net margin of approximately 27%. The company generated strong operating cash flow of CNY 7.07 billion, significantly exceeding capital expenditures of CNY 1.6 billion, indicating efficient capital deployment and solid cash generation capabilities. This operational efficiency supports ongoing investments in capacity expansion and technological upgrades while maintaining financial flexibility.
The company exhibits substantial earnings power with diluted EPS of CNY 1.91, reflecting effective utilization of its asset base. NHU's capital expenditure strategy appears disciplined, with investments focused on maintaining technological leadership and expanding high-margin product lines. The significant positive operating cash flow relative to capital requirements suggests strong fundamental profitability and efficient working capital management across its diversified business segments.
NHU maintains a solid financial position with cash and equivalents of CNY 7.94 billion against total debt of CNY 6.49 billion, indicating comfortable liquidity and moderate leverage. The company's balance sheet strength provides ample capacity to fund strategic initiatives and weather industry cyclicality. The conservative debt profile relative to cash reserves underscores management's disciplined approach to financial risk management.
The company has demonstrated consistent profitability with a dividend per share of CNY 0.50, reflecting a balanced approach to capital allocation between shareholder returns and reinvestment for growth. NHU's diversified product portfolio positions it to benefit from long-term trends in nutrition, healthcare, and advanced materials, while its established market presence provides a platform for both organic expansion and strategic market penetration.
With a market capitalization of approximately CNY 74.4 billion, NHU trades at a P/E multiple derived from its current earnings, reflecting market expectations for sustained profitability in its specialty chemical segments. The beta of 0.728 suggests lower volatility relative to the broader market, potentially indicating investor perception of stable cash flows from its diversified business model and established market positions.
NHU's competitive advantages stem from its integrated manufacturing capabilities, technological expertise in complex chemical synthesis, and diversified product portfolio serving multiple growth sectors. The company's outlook appears favorable given increasing global demand for nutritional products, specialty polymers, and pharmaceutical ingredients. Continued focus on R&D and operational efficiency should support NHU's ability to maintain its market leadership while exploring new growth opportunities in adjacent specialty chemical markets.
Company Annual ReportStock Exchange Disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |